Abstract

11510Background: EGFR mutation (MT) and ALK rearrangement (RR) testing is standard of care for advanced stage LUCA due to effective targeted therapies. Testing for additional driver alterations in ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call